Priority vs Standard Review: How FDA Prioritizes Generic Drug Applications
The FDA uses priority and standard review timelines to speed up or delay generic drug approvals. Priority review cuts approval time from 10 to 8 months - but only for first generics, drugs in shortage, or U.S.-made products. Learn how the system works and what it means for patients and manufacturers.
Read More